Yttrium-90 Anti-CD45 Immunotherapy Followed by Autologous Hematopoietic Cell Transplantation for Relapsed or Refractory Lymphoma-论文-万方医学网

首页> > Yttrium-90 Anti-CD45 Immunotherapy Followed by Autologous Hematopoietic Cell Transplantation for Relapsed or Refractory Lymphoma

Yttrium-90 Anti-CD45 Immunotherapy Followed by Autologous Hematopoietic Cell Transplantation for Relapsed or Refractory Lymphoma

导出原文传递

翻译打印收藏纠错

作者： Sherilyn A Tuazon ^[1] ; Ryan D Cassaday ; Theodore A Gooley ; Brenda M Smaier ; Leona A Holmberg ; Stephen D Smith ; David G Maloney ; Brian G Till ; Daniel B Martin ; Victor A Chow ; Joseph G Rajendran ; Darrell R Fisher ; Manuela C Matesan ; Sally J Lundberg ; Damian J Green ; John M Pagel ; Oliver W Press ; Ajay K Gopal

作者单位： Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington ^[1]

关键词 Radiotherapy Immunotherapy Anti-CD45 Antibody-radionuclide conjugate Lymphoma

发布时间 2022-09-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Yttrium-90 Anti-CD45 Immunotherapy Followed by Autologous Hematopoietic Cell Transplantation for Relapsed or Refractory Lymphoma

相似文献

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Yttrium-90 Anti-CD45 Immunotherapy Followed by Autologous Hematopoietic Cell Transplantation for Relapsed or Refractory Lymphoma

相似文献

相关期刊

检索历史清除